Opus Genetics, Inc.: cashflow_financing
| Value | {"amount": 27595000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | Opus Genetics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:00:05.893770+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/793854fb-7c94-4b15-b34c-e55aa8bb8f54
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-26-034084Retrieved: 2026-08-19T12:00:05.893770+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001228627/cashflow-financing/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/793854fb-7c94-4b15-b34c-e55aa8bb8f54
History
- no predecessors — first report